AR013838A1 - Compuestos de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b]benzodiazepina-dihidratos; los dihidratos b,d y e de dicho compuesto y proceso para preparar la forma ii sustancialmente pura de la olanzapina a partir de dichos dihidratos - Google Patents

Compuestos de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b]benzodiazepina-dihidratos; los dihidratos b,d y e de dicho compuesto y proceso para preparar la forma ii sustancialmente pura de la olanzapina a partir de dichos dihidratos

Info

Publication number
AR013838A1
AR013838A1 ARP970104362A ARP970104362A AR013838A1 AR 013838 A1 AR013838 A1 AR 013838A1 AR P970104362 A ARP970104362 A AR P970104362A AR P970104362 A ARP970104362 A AR P970104362A AR 013838 A1 AR013838 A1 AR 013838A1
Authority
AR
Argentina
Prior art keywords
olanzapine
dihydrates
methyl
substantially pure
piperazinyl
Prior art date
Application number
ARP970104362A
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR013838(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR013838A1 publication Critical patent/AR013838A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP970104362A 1996-09-23 1997-09-23 Compuestos de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b]benzodiazepina-dihidratos; los dihidratos b,d y e de dicho compuesto y proceso para preparar la forma ii sustancialmente pura de la olanzapina a partir de dichos dihidratos AR013838A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23

Publications (1)

Publication Number Publication Date
AR013838A1 true AR013838A1 (es) 2001-01-31

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104362A AR013838A1 (es) 1996-09-23 1997-09-23 Compuestos de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b]benzodiazepina-dihidratos; los dihidratos b,d y e de dicho compuesto y proceso para preparar la forma ii sustancialmente pura de la olanzapina a partir de dichos dihidratos

Country Status (35)

Country Link
US (1) US6020487A (enEXAMPLES)
EP (1) EP0831098B1 (enEXAMPLES)
JP (2) JP2001500877A (enEXAMPLES)
KR (1) KR100560015B1 (enEXAMPLES)
CN (1) CN1122036C (enEXAMPLES)
AR (1) AR013838A1 (enEXAMPLES)
AT (1) ATE209208T1 (enEXAMPLES)
AU (1) AU719441B2 (enEXAMPLES)
BR (1) BR9712100A (enEXAMPLES)
CA (1) CA2265712C (enEXAMPLES)
CO (1) CO4910140A1 (enEXAMPLES)
CZ (1) CZ299248B6 (enEXAMPLES)
DE (1) DE69708428T2 (enEXAMPLES)
DK (1) DK0831098T3 (enEXAMPLES)
EA (1) EA001642B1 (enEXAMPLES)
EG (1) EG23861A (enEXAMPLES)
ES (1) ES2166051T3 (enEXAMPLES)
HU (1) HU226484B1 (enEXAMPLES)
ID (1) ID27275A (enEXAMPLES)
IL (1) IL128962A (enEXAMPLES)
IN (1) IN187156B (enEXAMPLES)
MY (1) MY125565A (enEXAMPLES)
NO (1) NO323980B1 (enEXAMPLES)
NZ (1) NZ334448A (enEXAMPLES)
PE (1) PE110398A1 (enEXAMPLES)
PL (3) PL196068B1 (enEXAMPLES)
PT (1) PT831098E (enEXAMPLES)
RS (1) RS49598B (enEXAMPLES)
SI (1) SI0831098T1 (enEXAMPLES)
SV (1) SV1997000081A (enEXAMPLES)
TR (1) TR199900640T2 (enEXAMPLES)
TW (1) TW470746B (enEXAMPLES)
UA (1) UA59371C2 (enEXAMPLES)
WO (1) WO1998012199A1 (enEXAMPLES)
ZA (1) ZA978515B (enEXAMPLES)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004507548A (ja) * 2000-08-31 2004-03-11 ドクター・レディーズ・ラボラトリーズ・リミテッド オランザピン水和物の調製方法、及びこれを結晶形態のオランザピンに変換する方法
US6740753B2 (en) * 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
AU2002340328A1 (en) * 2001-10-29 2003-05-12 Janet I. Cord Olanzapine dihydrate-ii a process for its preparation and use thereof
JP4530664B2 (ja) 2001-12-24 2010-08-25 サン・ファーマシューティカル・インダストリーズ・リミテッド ２−メチル−４−（４−メチル−１−ピペラジニル）−１０Ｈ−チエノ［２，３−ｂ］［１，５］ベンゾジアゼピンの結晶形Ｉ、この結晶形Ｉの製造方法、及び医薬組成物
AU2003243153A1 (en) * 2002-04-23 2003-11-10 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
AU2003237305A1 (en) * 2002-05-31 2003-12-19 Geneva Pharmaceuticals, Inc. Process of preparation of olanzapine form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
US7323459B2 (en) 2002-12-24 2008-01-29 Teva Pharmaceutical Industries Ltd. Crystal forms, methods for their preparation and method for preparation of olanzapine
JP2007511605A (ja) * 2003-11-18 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー オランザピン含有経皮薬物送達組成物
JP2007515428A (ja) * 2003-12-22 2007-06-14 テバ ファーマシューティカル インダストリーズ リミティド オランザピンの合成方法
WO2005070938A1 (en) 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
US20070072845A1 (en) * 2004-02-19 2007-03-29 Davuluri Rammohan Rao Process for the preparation of olanzapine form 1 useful as antipsychotic drug
WO2006006185A1 (en) * 2004-07-14 2006-01-19 Shasun Chemicals And Drugs Limited Improved process for making form i of olanzapine.
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
US7829700B2 (en) 2004-09-06 2010-11-09 Shasun Chemicals And Drugs Limited Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
KR20130030305A (ko) * 2004-11-16 2013-03-26 엘란 파마 인터내셔널 리미티드 주사가능한 나노입자형 올란자핀 제형
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
EP0582368B1 (en) * 1992-05-29 2001-01-24 Eli Lilly And Company Limited Thienobenzodiazepine derivatives for treatment of CNS disorders
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
IL128956A0 (en) * 1996-09-23 2000-02-17 Lilly Co Eli Olanzapine dihydrate D

Also Published As

Publication number Publication date
ID27275A (id) 2001-03-22
WO1998012199A1 (en) 1998-03-26
NZ334448A (en) 2000-08-25
HU226484B1 (en) 2009-03-02
JP2009242407A (ja) 2009-10-22
UA59371C2 (uk) 2003-09-15
ATE209208T1 (de) 2001-12-15
KR20000048520A (ko) 2000-07-25
PL332482A1 (en) 1999-09-13
TR199900640T2 (xx) 1999-06-21
CA2265712C (en) 2006-10-31
EP0831098B1 (en) 2001-11-21
US6020487A (en) 2000-02-01
KR100560015B1 (ko) 2006-03-15
CA2265712A1 (en) 1998-03-26
EA199900326A1 (ru) 1999-08-26
EA001642B1 (ru) 2001-06-25
IL128962A0 (en) 2000-02-17
NO991382L (no) 1999-03-22
EP0831098A3 (en) 1998-04-29
CO4910140A1 (es) 2000-04-24
ES2166051T3 (es) 2002-04-01
YU15599A (sh) 2001-12-26
DK0831098T3 (da) 2002-05-21
EG23861A (en) 2007-11-18
DE69708428D1 (de) 2002-01-03
CZ299248B6 (cs) 2008-05-28
EP0831098A2 (en) 1998-03-25
JP2001500877A (ja) 2001-01-23
SI0831098T1 (en) 2002-04-30
PL196069B1 (pl) 2007-12-31
SV1997000081A (es) 1999-01-14
HUP0000066A3 (en) 2000-11-28
AU719441B2 (en) 2000-05-11
HUP0000066A2 (hu) 2000-06-28
RS49598B (sr) 2007-06-04
ZA978515B (en) 1999-03-23
DE69708428T2 (de) 2002-07-04
CN1234802A (zh) 1999-11-10
PE110398A1 (es) 1999-01-14
IN187156B (enEXAMPLES) 2002-02-16
MY125565A (en) 2006-08-30
PL194565B1 (pl) 2007-06-29
CZ99099A3 (cs) 1999-11-17
PT831098E (pt) 2002-04-29
TW470746B (en) 2002-01-01
BR9712100A (pt) 1999-08-31
HK1009807A1 (en) 1999-06-11
NO323980B1 (no) 2007-07-30
CN1122036C (zh) 2003-09-24
AU4484197A (en) 1998-04-14
NO991382D0 (no) 1999-03-22
PL196068B1 (pl) 2007-12-31
IL128962A (en) 2003-01-12

Similar Documents

Publication Publication Date Title
AR013838A1 (es) Compuestos de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b]benzodiazepina-dihidratos; los dihidratos b,d y e de dicho compuesto y proceso para preparar la forma ii sustancialmente pura de la olanzapina a partir de dichos dihidratos
ES2191977T3 (es) Soluciones y dispersiones en estado solido de farmacos poco solubles en agua.
Bonser et al. The carcinogenic properties of 2-amino-1-naphthol hydrochloride and its parent amine 2-naphthylamine
PE20020179A1 (es) DERIVADOS DE (6S,9R,10S,11S,13S,16R, 17R)-9-CLORO-6-FLUORO-11-HIDROXI-10,13,16-TRIMETIL-3-OXO-6,7,8,9,10,11,12,13,14,15,16,17-DODECAHIDRO-3H-CICLOPENTA[a]FENANTRENO CARBOXILICO
GT200000168A (es) Compuestos farmaceuticamente activos.
PE50795A1 (es) Dispositivo de administracion de progesterona
SV2002000232A (es) Derivados nuevos de benzoimidazole utiles como agentes antiproliferativos ref. pc 10608abcz/bb
GT200000171A (es) Compuestos farmaceuticamente activos.
PE55998A1 (es) Derivados 19-nor-pregneno substituidos
AR026064A1 (es) Compuestos de oxabispidina, formulacion farmaceutica, uso de estos compuestos para la manufactura de medicamentos, proceso para la preparacion de estos compuestos, e intermediarios.
ES2193658T3 (es) Procedimiento para la preparacion de formulaciones acuosas para uso oftalmico.
PE20030612A1 (es) Benzoimidazoles
BR0112014A (pt) Processo para a preparação de uma composição farmacêutica e, composição resultante
PA8487601A1 (es) Derivados biciclicos sustituidos utiles como agentes contra el cancer
UY25148A1 (es) Método para producir una composición farmacéutica que comprende un análogo de ácido gama aminobutírico (gaba) y una droga antiinflamatoria no esteroide (nsaid)
ES2140391T3 (es) Derivados de dialcoxi-piridinil-bencimidazol, procedimiento para su preparacion y su uso farmaceutico.
AR024013A1 (es) Preparado farmaceutico con diamorfina como sustancia activa, y su utilizacion en un procedimiento para el tratamiento de la adiccion a los opiaceos
SV2002000696A (es) Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgesicos pc9985ahxk/bb
PE20060555A1 (es) Derivados de pirrol-oxindol como moduladores del receptor de progesterona
ES2182079T3 (es) Composiciones farmaceuticas de liberacion sostenida que contienen un derivado de dibenzotiazepina.
ES2196803T3 (es) Procedimiento en fase acuosa para fabricar dispersiones solidas de paroxetina.
ES2178268T3 (es) Formulaciones de liberacion controlada.
DK2308496T3 (da) Formulering indeholdende fosfatderivater af elektrontransfermidler
ES2060015T3 (es) Derivados arilicos anti-inflamatorios.
BR9915018A (pt) Modificação de cristal da torasemida

Legal Events

Date Code Title Description
FC Refusal